Next Wave of Diagnostics, Including Precision IO: Early and Smarter, the Better to Cure

Wednesday, May 6, 2020 | 8:15 – 9:30 am


  • Brian Leyland Jones, MBBS, PhD, VP, Avera Cancer Institute Center for Precision Oncology & Dept. of Molecular & Experimental Medicine, Avera Cancer Institute


  • David Fabrizio, VP, Product Development, Foundation Medicine, Inc
  • Colin Hill, CEO, Co-founder & Chairman, GNS Healthcare, Inc.
  • Christoph Lengauer, PhD, MBA, Chief Innovation Officer, Thrive Earlier Detection Corp.
  • Jimmy Lin, MD, PhD, MHS, CSO, Freenome
  • Adam G. Marsh, PhD, CSO & CO-Founder, Genome Profiling, LLC
  • Tariq Sethi, PhD, CSO, Oncimmune